Purpose: To study the prevalence of risk factors for systemic thromboemboli
sm in patients with retinal vein thrombosis (RVT),
Methods: Fifty-four patients younger than 70 years, diagnosed with a retina
l vein thrombosis at the Department of Ophthalmology, Arhus University Hosp
ital, were examined for the presence of venous thrombosis risk factors.
Results: 23 patients had a central RVT, 26 had a branch RVT, and 4 had a ma
cular RVT Nineteen (35.2%) of the patients displayed increased levels of pl
asma homocysteine, one patient (1.9%) the Factor V Leiden mutation, and one
patient (1.9%) displayed an antiphospholipid antibody. All other tests for
thrombophilia rendered normal. In 15 of the patients with hyperhomocystein
emia, folic acid substitution returned plasma homocysteine to a normal valu
e in 12 cases.
Conclusion: A surprisingly high prevalence of hyperhomocysteinemia was dete
cted in this cohort of RVT patients, clearly superseding the prevalence of
around 17% found in patients suffering venous thromboembolism in other vasc
ular compartments. Our finding points to the likelihood that hyperhomocyste
inemia may be a significant risk factor for retinal vein thrombosis.